Tissue Transglutaminase Activation Modulates Inflammation in Cystic Fibrosis via PPARγ Down-Regulation1
暂无分享,去创建一个
V. Villella | V. Raia | L. Maiuri | M. Pettoello‐Mantovani | S. Quaratino | M. Londei | I. Giardino | C. Ciacci | A. Luciani | M. Cimmino | S. Guido | O. Cexus | M. d’Apolito | Stefano Guido
[1] J. Gustafson,et al. Cystic Fibrosis , 2009, Journal of the Iowa Medical Society.
[2] D. Matei,et al. Enhanced peritoneal ovarian tumor dissemination by tissue transglutaminase. , 2007, Cancer research.
[3] C. Khosla,et al. Transglutaminase 2 inhibitors and their therapeutic role in disease states. , 2007, Pharmacology & therapeutics.
[4] S. Gygi,et al. Host Resistance to Lung Infection Mediated by Major Vault Protein in Epithelial Cells , 2007, Science.
[5] V. Bours,et al. Role of IKK and ERK pathways in intrinsic inflammation of cystic fibrosis airways. , 2007, Biochemical pharmacology.
[6] R. Boucher,et al. The epithelium as a target for therapy in cystic fibrosis. , 2007, Current opinion in pharmacology.
[7] J. Kolls,et al. Is cystic fibrosis a TH17 disease? , 2007, Inflammation Research.
[8] A. Verkman,et al. CFTR inhibition mimics the cystic fibrosis inflammatory profile. , 2007, American journal of physiology. Lung cellular and molecular physiology.
[9] Soo-Youl Kim,et al. Reversal of Drug Resistance in Breast Cancer Cells by Transglutaminase 2 Inhibition and Nuclear Factor-KB Inactivation , 2006 .
[10] So Ri Kim,et al. Modulation of Airway Remodeling and Airway Inflammation by Peroxisome Proliferator-Activated Receptor γ in a Murine Model of Toluene Diisocyanate-Induced Asthma1 , 2006, The Journal of Immunology.
[11] S. Fiorucci,et al. PPARs and other nuclear receptors in inflammation. , 2006, Current opinion in pharmacology.
[12] M. Belvisi,et al. Peroxisome proliferator-activated receptor gamma agonists as therapy for chronic airway inflammation. , 2006, European journal of pharmacology.
[13] S. Yi,et al. [Ca(2+)]-dependent generation of intracellular reactive oxygen species mediates maitotoxin-induced cellular responses in human umbilical vein endothelial cells. , 2006, Molecules and cells.
[14] E. Rietschel,et al. Oxidative changes of bronchoalveolar proteins in cystic fibrosis. , 2006, Chest.
[15] C. Thiemermann,et al. Modulation of the oxidative stress and inflammatory response by PPAR-gamma agonists in the hippocampus of rats exposed to cerebral ischemia/reperfusion. , 2006, European journal of pharmacology.
[16] V. Raia,et al. Unexpected role of surface transglutaminase type II in celiac disease. , 2005, Gastroenterology.
[17] S. Ghosh,et al. 'PPAR'ting ways with inflammation , 2005, Nature Immunology.
[18] Michael Karin,et al. NF-κB: linking inflammation and immunity to cancer development and progression , 2005, Nature Reviews Immunology.
[19] V. Raia,et al. Inhibition of p38 mitogen activated protein kinase controls airway inflammation in cystic fibrosis , 2005, Thorax.
[20] R. Boucher,et al. Cystic Fibrosis Airway Epithelial Ca2+i Signaling , 2005, Journal of Biological Chemistry.
[21] Linghong Huang,et al. Inhibition of Transglutaminase Activity Reduces Extracellular Matrix Accumulation Induced by High Glucose Levels in Proximal Tubular Epithelial Cells* , 2004, Journal of Biological Chemistry.
[22] R. Cerione,et al. Augmentation of Tissue Transglutaminase Expression and Activation by Epidermal Growth Factor Inhibit Doxorubicin-induced Apoptosis in Human Breast Cancer Cells* , 2004, Journal of Biological Chemistry.
[23] A. Ferrando,et al. Decreased expression of peroxisome proliferator activated receptor γ in CFTR−/− mice , 2004 .
[24] T. Chase,et al. Tissue transglutaminase catalyzes the formation of alpha‐synuclein crosslinks in Parkinson's disease , 2004, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.
[25] J. Vance,et al. The Deacetylase HDAC6 Regulates Aggresome Formation and Cell Viability in Response to Misfolded Protein Stress , 2003, Cell.
[26] Fumiaki Tanaka,et al. Aggresomes protect cells by enhancing the degradation of toxic polyglutamine-containing protein. , 2003, Human molecular genetics.
[27] Soo-Youl Kim,et al. Tissue transglutaminase-induced aggregation of α-synuclein: Implications for Lewy body formation in Parkinson's disease and dementia with Lewy bodies , 2003, Proceedings of the National Academy of Sciences of the United States of America.
[28] Robert M. Graham,et al. Transglutaminases: crosslinking enzymes with pleiotropic functions , 2003, Nature Reviews Molecular Cell Biology.
[29] C. Ross,et al. Transglutaminase Cross‐Links in Intranuclear Inclusions in Huntington Disease , 2003, Journal of neuropathology and experimental neurology.
[30] Dallas Jones,et al. Emerging roles of PPARS in inflammation and immunity , 2002, Nature Reviews Immunology.
[31] Feng Gao,et al. Diversity Considerations in HIV-1 Vaccine Selection , 2002, Science.
[32] K. Fischbeck,et al. Toxic Proteins in Neurodegenerative Disease , 2002, Science.
[33] John Geibel,et al. Calcium-pump inhibitors induce functional surface expression of ΔF508-CFTR protein in cystic fibrosis epithelial cells , 2002, Nature Medicine.
[34] R. Kopito,et al. Aggresomes, inclusion bodies and protein aggregation. , 2000, Trends in cell biology.
[35] B. Spiegelman,et al. Degradation of the Peroxisome Proliferator-activated Receptor γ Is Linked to Ligand-dependent Activation* , 2000, The Journal of Biological Chemistry.
[36] J. Cavaillon,et al. Distinct sputum cytokine profiles in cystic fibrosis and other chronic inflammatory airway disease. , 1999, The European respiratory journal.
[37] R. Kopito,et al. Aggresomes: A Cellular Response to Misfolded Proteins , 1998, The Journal of cell biology.
[38] E. Greenberg,et al. Cystic Fibrosis Airway Epithelia Fail to Kill Bacteria Because of Abnormal Airway Surface Fluid , 1996, Cell.
[39] T. McBride. VEGETABLE MORPHOLOGY A CENTURY AGO. -- Goethe. , 1885, Science.
[40] T. Chin,et al. Dual effect of thapsigargin on cell death in porcine aortic smooth muscle cells. , 2007, American journal of physiology. Cell physiology.
[41] R. Boucher,et al. Cystic Fibrosis Airway Epithelial Ca 2 i Signaling THE MECHANISM FOR THE LARGER AGONIST-MEDIATED Ca , 2005 .
[42] S. Pettersson,et al. Commensal anaerobic gut bacteria attenuate inflammation by regulating nuclear-cytoplasmic shuttling of PPAR-γ and RelA , 2004, Nature Immunology.